Sort   by:  
 Page size 
UnknownM-CSF as a therapeutic target in BRAFV600E melanoma resistant to BRAF inhibitors.
Not available
S-EPMC9470708 | biostudies-literature
UnknownAssociation of Melanocortin-1 Receptor Variants with Pigmentary Traits in Humans: A Pooled Analysis from the M-Skip Project.
Not available
S-EPMC5317175 | biostudies-literature
UnknownLack of Mutations in POT1 Gene in Selected Families with Familial Non-Medullary Thyroid Cancer.
Not available
S-EPMC10355240 | biostudies-literature
UnknownUpdate in genetic susceptibility in melanoma.
Not available
S-EPMC4583600 | biostudies-literature
UnknownRole of CPI-17 in restoring skin homoeostasis in cutaneous field of cancerization: effects of topical application of a film-forming medical device containing photolyase and UV filters.
Not available
S-EPMC3748792 | biostudies-literature
UnknownIncidental pathogenic germline alterations detected through liquid biopsy in patients with solid tumors: prevalence, clinical utility and implications.
Not available
S-EPMC11059286 | biostudies-literature
UnknownDermoscopy comparative approach for early diagnosis in familial melanoma: influence of MC1R genotype.
Not available
S-EPMC9290446 | biostudies-literature
UnknownEfficacy of BRAF and MEK Inhibition in Patients with BRAF-Mutant Advanced Melanoma and Germline CDKN2A Pathogenic Variants.
Not available
S-EPMC8157545 | biostudies-literature
UnknownCommon genetic variants associated with melanoma risk or naevus count in patients with wildtype MC1R melanoma.
Not available
S-EPMC9804579 | biostudies-literature
UnknownPOT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families.
Not available
S-EPMC6526091 | biostudies-literature
Sort   by:  
 Page size